This is based on β-catenin's established importance in regulating osteoblastogenesis [33], [34], as well as reports that inhibition and overexpression of Cldn-1 in a colon cancer cell line leads to a reduction and activation of β-catenin signaling, respectively [35], [36]. The gene discussed is CLDN1; the disease is malignant colon neoplasm.